# Genetron Holdings

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genetron-holdings

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.genetronhealth.com
- Total disclosed funding: $133M
- Latest round: Series D (Nov 21, 2019)
- Investors on record: 12

## About

Founded in 2013 and based in Beijing, China, Genetron Holdings Limited operates as a developer of precision medical products to provide cancer patients with molecular diagnosis and therapeutics. The company's platform offers human IDH1/TERT promoter mutation detection kit, biochip reader Genetron 3D, and Genetron S5.

## Funding rounds

- Series D, Nov 21, 2019, $71M — Alexandria Venture Investments, Vivo Capital, China International Capital Corporation, HighLight Capital
- Series C, Jan 4, 2018, $62M — V Star Capital, Zhongjin Kangrui Medical Industrial Fund, Shenshang Xingye Fund
- Series B, Sep 20, 2016 — New Horizon Capital, Share Capital, VCANBIO Cell & Gene Engineering Corp., Ltd, In Capital, Jiadaogu Capital

## Investors

- New Horizon Capital — Series B
- Share Capital (https://capitalatlas.ai/funds/share-capital) — Series B
- VCANBIO Cell & Gene Engineering Corp., Ltd — Series B
- In Capital — Series B
- Jiadaogu Capital (https://capitalatlas.ai/funds/jiadaogu-capital) — Series B
- V Star Capital (https://capitalatlas.ai/funds/v-star-capital) — Series C
- Zhongjin Kangrui Medical Industrial Fund — Series C
- Shenshang Xingye Fund — Series C
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series D
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series D
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series D
- HighLight Capital (https://capitalatlas.ai/funds/highlight-capital) — Series D